Beta-Sitosterol Alters Collagen Distribution in Prostate Fibroblasts.

Beta-sitosterol collagen fibroblast prostate stroma supplement

Journal

Journal of dietary supplements
ISSN: 1939-022X
Titre abrégé: J Diet Suppl
Pays: England
ID NLM: 101249830

Informations de publication

Date de publication:
07 Nov 2023
Historique:
medline: 7 11 2023
pubmed: 7 11 2023
entrez: 7 11 2023
Statut: aheadofprint

Résumé

Herbal supplements containing several types of plant sterols, vitamins, and minerals, are marketed for prostate health. In the majority of these supplements, the most abundant plant sterol is saw palmetto extract or its' principal component, beta-sitosterol. In terms of prostate health, previous work almost exclusively focused on the effects of beta-sitosterol on prostatic epithelium, with little attention paid to the effects on prostatic stroma. This omission is a concern, as the abnormal accumulation of collagen, or fibrosis, of the prostatic stroma has been identified as a factor contributing to lower urinary tract symptoms and dysfunction in aging men. To address whether beta-sitosterol may be promoting prostatic fibrosis, immortalized and primary prostate stromal fibroblasts were subjected to immunoblotting, immunofluorescence, qRT-PCR, ELISA, and image quantitation and analysis techniques to elucidate the effects of beta-sitosterol on cell viability and collagen expression and cellular localization. The results of these studies show that beta-sitosterol is nontoxic to prostatic fibroblasts and does not stimulate collagen production by these cells. However, beta-sitosterol alters collagen distribution and sequesters collagen within prostatic fibroblasts, likely in an age-dependent manner. This is a significant finding as prostate health supplements are used predominantly by middle aged and older men who may, then, be affected disproportionately by these effects.

Identifiants

pubmed: 37933457
doi: 10.1080/19390211.2023.2276943
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-14

Auteurs

Quentin D'Arcy (Q)

Center for Personalized Cancer Therapy, The University of MA Boston, Boston, MA, USA.
Department of Biology, The University of Massachusetts Boston, Boston, MA, USA.

Marissa Sarna-McCarthy (M)

Center for Personalized Cancer Therapy, The University of MA Boston, Boston, MA, USA.
Department of Biology, The University of Massachusetts Boston, Boston, MA, USA.

Delaney Bowen (D)

Center for Personalized Cancer Therapy, The University of MA Boston, Boston, MA, USA.
Department of Biology, The University of Massachusetts Boston, Boston, MA, USA.

Fidias O Soto (FO)

Center for Personalized Cancer Therapy, The University of MA Boston, Boston, MA, USA.
Department of Biology, The University of Massachusetts Boston, Boston, MA, USA.

Kourosh Zarringhalam (K)

Center for Personalized Cancer Therapy, The University of MA Boston, Boston, MA, USA.
Department of Mathematics, The University of Massachusetts Boston, Boston, MA, USA.

Jill A Macoska (JA)

Center for Personalized Cancer Therapy, The University of MA Boston, Boston, MA, USA.
Department of Biology, The University of Massachusetts Boston, Boston, MA, USA.

Classifications MeSH